ArticleFrontiers in endocrinology2025
Cost-effectiveness analysis of second-line medical therapies in acromegaly: a real-life study.
Eva Venegas Moreno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it